Literature DB >> 16818277

Antigen receptors and somatic hypermutation in B-cell chronic lymphocytic leukemia with Richter's transformation.

Laura A Smit1, Febe van Maldegem, Anton W Langerak, C Ellen van der Schoot, Mireille J de Wit, Silvia Bea, Elias Campo, Richard J Bende, Carel J M van Noesel.   

Abstract

BACKGROUND AND OBJECTIVES: Activation-induced cytidine deaminase is essential for somatic hypermutation and class switch recombination of the immunoglobulin genes in B cells. It has been proposed that aberrant targeting of the somatic hypermutation machinery is instrumental in initiation and progression of B-cell non Hodgkin's lymphomas. In this study, we investigated the B-cell receptor and the role of the somatic hypermutation machinery in B-cell chronic lymphocytic leukemias (B-CLL) prior to and after transformation to a lymphoma of a higher malignancy grade (Richter's transformation). DESIGN AND METHODS: We investigated the activity of the somatic hypermutation machinery in nine B-CLL and secondary diffuse large B-cell lymphomas by measuring the expression of activation-induced cytidine deaminase, in combination with mutation analysis of immunoglobulin (Ig) and non-Ig genes. Furthermore, the structure of the antigen receptors of B-CLL known to have developed a Richter's syndrome (RS B-CLL) was analyzed by comparing the most variable region of the Ig, the CDR3 region, to CDR3 sequences present in GenBank.
RESULTS: Ig variable heavy chain (IgV(H)) gene studies revealed that Richter's transformation occurs almost exclusively in unmutated B-CLL. Furthermore, activated-induced cytidine deaminase expression and somatic hypermutation activity of most RS B-CLL were found to be higher than those of control (non-transforming) B-CLL. Finally, comparison of the IgVH-CDR3 regions showed a remarkable amino acid sequence homology between two RS B-CLL of our panel and two RS B-CLL described in the literature. INTERPRETATIONS AND
CONCLUSIONS: The combined findings suggest a role for the Ig gene diversification apparatus during Richter's transformation and show that distinct RS-B-CLL may recognize recurrent antigenic epitopes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16818277

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  3 in total

Review 1.  Recent advances in the diagnosis and therapy of Richter's syndrome.

Authors:  Ronan Swords; John Bruzzi; Francis Giles
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

2.  IGHV gene rearrangements as outcome predictors for CLL patients: experience of Ukrainian group.

Authors:  I Kryachok; I Abramenko; N Bilous; A Chumak; Z Martina; I Filonenko
Journal:  Med Oncol       Date:  2011-03-04       Impact factor: 3.064

3.  Activation-induced deaminase and its splice variants associate with trisomy 12 in chronic lymphocytic leukemia.

Authors:  Kristina Zaprazna; Kamila Reblova; Veronika Svobodova; Lenka Radova; Vojtech Bystry; Jiri Baloun; Kristina Durechova; Nikola Tom; Tomas Loja; Martina Buresova; Kamila Stranska; Alexandra Oltova; Michael Doubek; Michael L Atchison; Martin Trbusek; Jitka Malcikova; Sarka Pospisilova
Journal:  Ann Hematol       Date:  2018-10-27       Impact factor: 3.673

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.